| Primary |
| Convulsion |
21.7% |
| Product Used For Unknown Indication |
19.6% |
| Epilepsy |
18.5% |
| Complex Partial Seizures |
5.4% |
| Partial Seizures |
5.4% |
| Bipolar Disorder |
3.3% |
| Drug Therapy |
3.3% |
| Schizoaffective Disorder |
3.3% |
| Schizophrenia |
3.3% |
| Acute Hepatic Failure |
2.2% |
| Brucellosis |
2.2% |
| Grand Mal Convulsion |
2.2% |
| Petit Mal Epilepsy |
2.2% |
| Febrile Convulsion |
1.1% |
| Affect Lability |
1.1% |
| Chorea |
1.1% |
| Cluster Headache |
1.1% |
| Convulsion Prophylaxis |
1.1% |
| Depression |
1.1% |
| Febrile Seizure |
1.1% |
|
| Toxic Epidermal Necrolysis |
13.5% |
| Malnutrition |
8.1% |
| Renal Tubular Disorder |
8.1% |
| Toxicity To Various Agents |
8.1% |
| Maternal Drugs Affecting Foetus |
5.4% |
| Meningomyelocele |
5.4% |
| Pancreatitis Acute |
5.4% |
| Parkinsonism |
5.4% |
| Sexually Inappropriate Behaviour |
5.4% |
| Tachycardia |
5.4% |
| Xanthoma |
5.4% |
| Alopecia |
2.7% |
| Drug Level Decreased |
2.7% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.7% |
| Ear Disorder |
2.7% |
| Encephalopathy |
2.7% |
| Epilepsy |
2.7% |
| Heart Rate Increased |
2.7% |
| Hyperammonaemic Encephalopathy |
2.7% |
| Intentional Overdose |
2.7% |
|
| Secondary |
| Product Used For Unknown Indication |
19.0% |
| Epilepsy |
16.2% |
| Convulsion |
14.6% |
| Status Epilepticus |
9.5% |
| Myoclonic Epilepsy |
7.5% |
| Bipolar Disorder |
6.3% |
| Hypertension |
4.7% |
| Hiv Infection |
4.3% |
| Infantile Spasms |
2.4% |
| Autism |
2.0% |
| Maternal Exposure Timing Unspecified |
2.0% |
| Convulsion Prophylaxis |
1.6% |
| Depression |
1.6% |
| Foetal Exposure During Pregnancy |
1.6% |
| Bipolar Ii Disorder |
1.2% |
| Cerebellar Infarction |
1.2% |
| Dementia Alzheimer's Type |
1.2% |
| Metastatic Renal Cell Carcinoma |
1.2% |
| Pneumonia Aspiration |
1.2% |
| Migraine Prophylaxis |
0.8% |
|
| Hypoglycaemia |
15.9% |
| Grand Mal Convulsion |
9.1% |
| Hypotonia |
9.1% |
| Drug Ineffective |
6.8% |
| Respiratory Disorder Neonatal |
6.8% |
| Speech Disorder |
6.8% |
| Drug Ineffective For Unapproved Indication |
4.5% |
| Hyperammonaemic Encephalopathy |
4.5% |
| Hyponatraemia |
4.5% |
| Slow Response To Stimuli |
4.5% |
| Toxic Epidermal Necrolysis |
4.5% |
| Vomiting |
4.5% |
| Accidental Exposure To Product |
2.3% |
| Acquired Haemophilia |
2.3% |
| Atrial Septal Defect |
2.3% |
| Convulsion |
2.3% |
| Cryptorchism |
2.3% |
| Delirium |
2.3% |
| Disorientation |
2.3% |
| Drug Exposure During Pregnancy |
2.3% |
|
| Concomitant |
| Epilepsy |
39.8% |
| Product Used For Unknown Indication |
24.2% |
| Bipolar Disorder |
6.6% |
| Convulsion |
6.6% |
| Status Epilepticus |
3.5% |
| Schizophrenia |
3.2% |
| Depression |
2.4% |
| Partial Seizures |
2.2% |
| Bipolar Ii Disorder |
1.7% |
| Acute Myeloid Leukaemia |
1.5% |
| Hypertension |
1.3% |
| Atrial Fibrillation |
1.0% |
| Breast Cancer |
1.0% |
| Nasopharyngitis |
0.8% |
| Relapsing-remitting Multiple Sclerosis |
0.8% |
| Agitated Depression |
0.7% |
| Anxiety |
0.7% |
| Diabetes Mellitus |
0.7% |
| Hiv Infection |
0.7% |
| Hypothyroidism |
0.7% |
|
| Status Epilepticus |
10.0% |
| Confusional State |
7.8% |
| Weight Decreased |
6.7% |
| Drug Ineffective |
5.6% |
| Epilepsy |
5.6% |
| Grand Mal Convulsion |
5.6% |
| Somnambulism |
5.6% |
| Tachycardia |
5.6% |
| Toxicity To Various Agents |
5.6% |
| Tremor |
5.6% |
| Convulsion |
4.4% |
| Rhabdomyolysis |
4.4% |
| Sepsis |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Mania |
3.3% |
| Overdose |
3.3% |
| Restless Legs Syndrome |
3.3% |
| Suicide Attempt |
3.3% |
| Vomiting |
3.3% |
| Drug Ineffective For Unapproved Indication |
2.2% |
|
| Interacting |
| Bipolar I Disorder |
30.4% |
| Hypertension |
17.4% |
| Anaesthesia |
8.7% |
| Epilepsy |
8.7% |
| Hormone Replacement Therapy |
8.7% |
| Neuralgia |
8.7% |
| Schizoaffective Disorder |
8.7% |
| Diabetes Mellitus |
4.3% |
| Hyperlipidaemia |
4.3% |
|
| Drug Interaction |
40.0% |
| Hyperammonaemic Encephalopathy |
20.0% |
| Overdose |
20.0% |
| Respiratory Alkalosis |
20.0% |
|
